Piotr Suchocki

1.1k total citations
49 papers, 892 citations indexed

About

Piotr Suchocki is a scholar working on Nutrition and Dietetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Piotr Suchocki has authored 49 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nutrition and Dietetics, 20 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Piotr Suchocki's work include Selenium in Biological Systems (24 papers), Glutathione Transferases and Polymorphisms (7 papers) and Fungal Biology and Applications (6 papers). Piotr Suchocki is often cited by papers focused on Selenium in Biological Systems (24 papers), Glutathione Transferases and Polymorphisms (7 papers) and Fungal Biology and Applications (6 papers). Piotr Suchocki collaborates with scholars based in Poland, Brazil and China. Piotr Suchocki's co-authors include Franciszek Herold, Wojciech Krzyczkowski, Eliza Malinowska, Jadwiga Turło, E. Mosiniewicz-Szablewska, P.C. Morais, Katarzyna Lubelska, Joanna Ślusarczyk, Mieczysław Kuraś and Marian Olejnik and has published in prestigious journals such as PLoS ONE, Journal of Applied Physics and Journal of Agricultural and Food Chemistry.

In The Last Decade

Piotr Suchocki

47 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Suchocki Poland 18 308 293 221 175 98 49 892
Andrea Cerrato Italy 21 576 1.9× 140 0.5× 195 0.9× 199 1.1× 105 1.1× 73 1.1k
Taigang Liang China 16 248 0.8× 217 0.7× 78 0.4× 195 1.1× 67 0.7× 41 759
Zhihua Lv China 18 382 1.2× 97 0.3× 161 0.7× 165 0.9× 139 1.4× 66 1.2k
Muhammad Hassham Hassan Bin Asad Pakistan 17 390 1.3× 89 0.3× 138 0.6× 208 1.2× 38 0.4× 59 1.3k
Carla Varela Portugal 20 383 1.2× 94 0.3× 133 0.6× 146 0.8× 60 0.6× 43 1.2k
Giovanni Di Fabio Italy 25 925 3.0× 116 0.4× 198 0.9× 226 1.3× 90 0.9× 116 1.8k
Jayeeta Das India 19 331 1.1× 54 0.2× 159 0.7× 167 1.0× 68 0.7× 27 982
Ju-Young Ko South Korea 21 563 1.8× 88 0.3× 78 0.4× 111 0.6× 51 0.5× 56 1.3k
Sreemanti Das India 19 378 1.2× 56 0.2× 161 0.7× 166 0.9× 81 0.8× 24 1.0k
Andrew P. Breksa United States 25 548 1.8× 191 0.7× 94 0.4× 644 3.7× 31 0.3× 53 1.5k

Countries citing papers authored by Piotr Suchocki

Since Specialization
Citations

This map shows the geographic impact of Piotr Suchocki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Suchocki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Suchocki more than expected).

Fields of papers citing papers by Piotr Suchocki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Suchocki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Suchocki. The network helps show where Piotr Suchocki may publish in the future.

Co-authorship network of co-authors of Piotr Suchocki

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Suchocki. A scholar is included among the top collaborators of Piotr Suchocki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Suchocki. Piotr Suchocki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fascineli, Maria Luiza, Eliza Carla Barroso Duarte, Da Silva, et al.. (2022). Combination of selol nanocapsules and magnetic hyperthermia hinders breast tumor growth in aged mice after a short-time treatment. Nanotechnology. 33(20). 205101–205101. 2 indexed citations
3.
Muszyńska, Bożena, Ewelina Szacawa, Dorota Bederska‐Łojewska, et al.. (2020). Preliminary study on Se-enriched Lentinula edodes mycelium as a proposal of new feed additive in selenium deficiency. PLoS ONE. 15(5). e0233456–e0233456. 8 indexed citations
4.
Woźniak, Katarzyna, et al.. (2018). Selol (Se IV) modulates adhesive molecules in control and TNF-α-stimulated HMEC-1 cells. Journal of Trace Elements in Medicine and Biology. 51. 106–114. 5 indexed citations
5.
Giebułtowicz, Joanna, et al.. (2018). Effects of Selol 5% supplementation on tissue antioxidant enzyme levels and peroxidation marker in healthy mice. Pharmacological Reports. 70(6). 1073–1078. 2 indexed citations
6.
Bamburowicz‐Klimkowska, Magdalena, et al.. (2016). A Search for the Optimum Selenium Source to Obtain Mushroom-Derived Chemopreventive Preparations. International journal of medicinal mushrooms. 18(4). 279–289. 5 indexed citations
7.
Muehlmann, Luís Alexandre, Rosana Simón‐Vázquez, Alfredo Maurício Batista de Paula, et al.. (2015). Antitumor activity and systemic effects of PVM/MA-shelled selol nanocapsules in lung adenocarcinoma-bearing mice. Nanotechnology. 26(50). 505101–505101. 10 indexed citations
8.
Ślusarczyk, Joanna, Monika Dudek, Małgorzata Wierzbicka, Piotr Suchocki, & Mieczysław Kuraś. (2014). Antimitotic effect of Selol and sodium selenate (IV) onAlliumtest cells. Caryologia. 67(3). 250–259. 12 indexed citations
9.
Muehlmann, Luís Alexandre, Rosana Simón‐Vázquez, Graziella Anselmo Joanitti, et al.. (2014). PVM/MA-shelled selol nanocapsules promote cell cycle arrest in A549 lung adenocarcinoma cells. Journal of Nanobiotechnology. 12(1). 32–32. 17 indexed citations
10.
Nowak, Karolina, et al.. (2011). Badania wpływu Selolu i seleninu sodu na komórki HeLa in vitro. Chemik. 65. 105–114. 5 indexed citations
11.
Jaworska, Małgorzata, et al.. (2010). Experimental immunology The effect of selenium on redox state and thiols changes in lung tissue after Selol, a new organoselenium (IV) compound, administration. Central European Journal of Immunology. 35(3). 1 indexed citations
12.
Rahden-Staroń, Iwonna, Piotr Suchocki, & Hanna Czeczot. (2010). Evaluation of mutagenic activity of the organo-selenium compound Selol by use of the Salmonella typhimurium mutagenicity assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 699(1-2). 44–46. 12 indexed citations
13.
Suchocki, Piotr, Irena Misiewicz-Krzemińska, Katarzyna Skupińska, et al.. (2010). Selenitetriglicerydes affect CYP1A1 and QR activity by involvement of reactive oxygen species and Nrf2 transcription factor. Pharmacological Reports. 62(2). 352–361. 18 indexed citations
14.
Czeczot, Hanna, et al.. (2007). Changes in antioxidant defense systems induced by thiram in V79 Chinese hamster fibroblasts. Toxicology in Vitro. 22(1). 28–35. 27 indexed citations
15.
Suchocki, Piotr, et al.. (2003). New HPLC method for separation of blood plasma phospholipids. Journal of Pharmaceutical and Biomedical Analysis. 32(4-5). 859–865. 20 indexed citations
16.
Pokorski, Mieczysław, et al.. (2003). Ascorbyl palmitate as a carrier of ascorbate into neural tissues. Journal of Biomedical Science. 10(2). 193–198. 32 indexed citations
17.
Marczak, Magdalena, et al.. (2003). Ascorbate in the Carotid Body. Advances in experimental medicine and biology. 536. 59–64. 2 indexed citations
18.
Zagrodzki, Paweł, et al.. (2000). Selenoenzymes in animal tissues after supplementation with SELOL. Bulletin of the Veterinary Institute in Pulawy. 44(2). 15 indexed citations
19.
Fijałek, Zbigniew, et al.. (1998). Polarographic and voltammetric studies of Selol a seleninoglyceride compound. Chemia Analityczna. 43(5). 833–841. 2 indexed citations
20.
Suchocki, Piotr, et al.. (1978). [Use of densitometry in the determination of active substances in drugs. I. Determination of various derivatives of phenothiazine and azepine in various forms of single drugs].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(2). 227–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026